JPH0456591B2 - - Google Patents

Info

Publication number
JPH0456591B2
JPH0456591B2 JP59242706A JP24270684A JPH0456591B2 JP H0456591 B2 JPH0456591 B2 JP H0456591B2 JP 59242706 A JP59242706 A JP 59242706A JP 24270684 A JP24270684 A JP 24270684A JP H0456591 B2 JPH0456591 B2 JP H0456591B2
Authority
JP
Japan
Prior art keywords
immobilized
fibrinolytic
sterilization
carrier
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59242706A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61124383A (ja
Inventor
Katsuhiko Suyama
Yasuki Yabushita
Masanao Koyama
Kunihiko Takagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitika Ltd
Original Assignee
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17093034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0456591(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unitika Ltd filed Critical Unitika Ltd
Priority to JP59242706A priority Critical patent/JPS61124383A/ja
Priority to DE8585308206T priority patent/DE3571329D1/de
Priority to EP85308206A priority patent/EP0182579B2/en
Priority to US06/799,239 priority patent/US4764466A/en
Publication of JPS61124383A publication Critical patent/JPS61124383A/ja
Publication of JPH0456591B2 publication Critical patent/JPH0456591B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A61L2103/05—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
JP59242706A 1984-11-16 1984-11-16 固定化線維素溶解活性酵素の安定化法 Granted JPS61124383A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP59242706A JPS61124383A (ja) 1984-11-16 1984-11-16 固定化線維素溶解活性酵素の安定化法
DE8585308206T DE3571329D1 (en) 1984-11-16 1985-11-12 Method for stabilizing immobilized fibrinolytic enzyme
EP85308206A EP0182579B2 (en) 1984-11-16 1985-11-12 Method for stabilizing immobilized fibrinolytic enzyme
US06/799,239 US4764466A (en) 1984-11-16 1985-11-18 Method for stabilizing an immobilized fibrinolytic enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59242706A JPS61124383A (ja) 1984-11-16 1984-11-16 固定化線維素溶解活性酵素の安定化法

Publications (2)

Publication Number Publication Date
JPS61124383A JPS61124383A (ja) 1986-06-12
JPH0456591B2 true JPH0456591B2 (OSRAM) 1992-09-08

Family

ID=17093034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59242706A Granted JPS61124383A (ja) 1984-11-16 1984-11-16 固定化線維素溶解活性酵素の安定化法

Country Status (4)

Country Link
US (1) US4764466A (OSRAM)
EP (1) EP0182579B2 (OSRAM)
JP (1) JPS61124383A (OSRAM)
DE (1) DE3571329D1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
US5141853A (en) * 1988-07-22 1992-08-25 Abbott Laboratories Determination of ammonia levels in a sample
WO1990009798A1 (en) * 1989-02-24 1990-09-07 Immunotherapeutics, Inc. Immobilized cytokines
US5279954A (en) * 1989-06-30 1994-01-18 Board Of Regents Of The University Of Nebraska And Bionebraska Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins
WO1991008288A1 (en) * 1989-11-23 1991-06-13 Novo Nordisk A/S An immobilized enzyme preparation whereby a basic amino acid has been incorporated and a process for the isomerization of glucose or xylose
US5468622A (en) * 1990-04-03 1995-11-21 Immunomatrix, Inc. Salt stabilization of antibody-enzyme conjugates heat-dried into paper
US5491082A (en) * 1991-03-18 1996-02-13 Director-General Of Agency Of Industrial Science And Technology Plasminogen activator covalently bonded to a porous body of β-tricalcium phosphate
JP2500330B2 (ja) * 1991-03-26 1996-05-29 工業技術院長 血栓溶解能を有する生体適合性材料
US5288489A (en) * 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
US5378232A (en) * 1991-08-28 1995-01-03 Orion Therapeutic Systems, Inc. Injection/activation apparatus
US5304118A (en) * 1992-12-16 1994-04-19 Trese Michael T Method for performing a vitrectomy on an eye
US6995248B2 (en) * 2001-07-16 2006-02-07 Dr. Chip Biotechnology, Inc. Immobilization of nucleic acids
US7776026B2 (en) * 2002-02-06 2010-08-17 Nuvue Technologies, Inc. Method for vitreous liquefaction
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US9818120B2 (en) 2015-02-20 2017-11-14 Innovative Global Systems, Llc Automated at-the-pump system and method for managing vehicle fuel purchases
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
AU2007247190A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US8545459B2 (en) 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
NZ602921A (en) 2010-05-05 2016-01-29 Boehringer Ingelheim Int Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1274869A (en) * 1969-02-11 1972-05-17 Guinness Son & Co Ltd A Enzymes
JPS5137343B2 (OSRAM) * 1972-12-07 1976-10-15
FR2308636A1 (fr) * 1975-04-23 1976-11-19 Choay Sa Matrices portant simultanement plusieurs fonctions enzymatiques differentes, leur procede de production, et procede de preparation d'oligonucleotides et de polynucleotides a terminaisons specifiques, a l'aide desdites matrices
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
US4226935A (en) * 1978-08-07 1980-10-07 W. R. Grace & Co. Enzymatic diagnostic composition
US4246349A (en) * 1978-09-05 1981-01-20 Corning Glass Works Stabilization of immobilized bacteria
DE3316601A1 (de) * 1983-05-06 1984-11-08 Battelle-Institut E.V., 6000 Frankfurt Verfahren zur immobilisierung von proteinen oder enzymen

Also Published As

Publication number Publication date
JPS61124383A (ja) 1986-06-12
DE3571329D1 (en) 1989-08-10
US4764466A (en) 1988-08-16
EP0182579A1 (en) 1986-05-28
EP0182579B1 (en) 1989-07-05
EP0182579B2 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
JPH0456591B2 (OSRAM)
US6969523B1 (en) Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation
JP6962901B2 (ja) 物理的操作または殺菌の後に大きな生物活性を有する固定化された生物活性物質
CN103037847B (zh) 用于制备干燥、稳定的止血组合物的方法
JP6195569B2 (ja) 止血組成物
US5182317A (en) Multifunctional thrombo-resistant coatings and methods of manufacture
US5342693A (en) Multifunctional thrombo-resistant coating and methods of manufacture
US20070009580A1 (en) Non-adhesive hydrogels
WO2007106582A2 (en) Preparation and storage of stable, biologically active materials
CN100356987C (zh) 带有凝血酶的生物可吸收合成非织造织物
JP2008523129A (ja) 二次元及び三次元ポリマー支持体の調製法
JP4252123B2 (ja) 固定化線維素溶解活性酵素の活性安定化法
US20090186332A1 (en) Preparation and storage of stable, antimicrobially active materials
JPS625599B2 (OSRAM)
JPH04285561A (ja) 医療用材料の滅菌方法および医療用器具の製造方法
JPS6087225A (ja) フイブリン形成促進材料の製造法
JPS6135829B2 (OSRAM)
JPH0431668B2 (OSRAM)
JPH05276945A (ja) 生理活性物質固定化シリコーン成形体の製造法
JPH0414032B2 (OSRAM)
Song et al. Preparation and characterization of oxygen generating (OG) hydrogels using γ-ray irradiation crosslinking
JP4848501B2 (ja) 放射線照射された改質基材
Lokapur Optimization of a dual enzyme system and its effect on collagenous surfaces
JPH0217527B2 (OSRAM)
JPS5931532B2 (ja) シリコ−ン樹脂表面に線維素溶解活性を付与する方法